Q-Line Biotech IPO Live GMP Today
As of 28 May 2026, 08:35 pm IST, Q-Line Biotech SME IPO is quoting a grey market premium of +₹125 (+36.4% over the issue price), implying a listing around ₹468 per share.
| Status | Listed |
| Type | SME |
| Open Date | May 21, 2026 |
| Close Date | May 25, 2026 |
| Listing Date | May 29, 2026 |
| Lot Size | 800 shares |
| Issue Size | ₹214.00 Cr |
| Date | GMP (Rs) | Change | GMP % | Est. Listing |
|---|---|---|---|---|
| May 28, 2026 08:35 pm | +125 | ▲ 5 | +36.4% | ₹468 |
| May 28, 2026 07:54 pm | +120 | ▼ 5 | +35.0% | ₹463 |
| May 28, 2026 07:43 am | +125 | ▲ 10 | +36.4% | ₹468 |
| May 27, 2026 08:18 pm | +115 | ▲ 7 | +33.5% | ₹458 |
| May 27, 2026 12:38 pm | +108 | ▲ 4 | +31.5% | ₹451 |
| May 26, 2026 07:35 pm | +104 | ▼ 11 | +30.3% | ₹447 |
| May 26, 2026 04:41 pm | +115 | ▲ 16 | +33.5% | ₹458 |
| May 25, 2026 03:07 pm | +99 | ▼ 26 | +28.9% | ₹442 |
| May 25, 2026 12:08 pm | +125 | ▼ 5 | +36.4% | ₹468 |
| May 23, 2026 10:34 am | +130 | ▲ 10 | +37.9% | ₹473 |
| May 22, 2026 09:45 am | +120 | ▼ 12 | +35.0% | ₹463 |
| May 21, 2026 09:57 pm | +132 | ▲ 22 | +38.5% | ₹475 |
| May 21, 2026 05:27 pm | +110 | ▼ 15 | +32.1% | ₹453 |
| May 21, 2026 04:15 pm | +125 | ▼ 10 | +36.4% | ₹468 |
| May 21, 2026 12:48 pm | +135 | ▼ 6 | +39.4% | ₹478 |
| May 21, 2026 07:36 am | +141 | ▲ 41 | +41.1% | ₹484 |
| May 20, 2026 07:59 pm | +100 | ▼ 11 | +29.2% | ₹443 |
| May 20, 2026 05:47 pm | +111 | ▼ 1 | +32.4% | ₹454 |
| May 20, 2026 01:40 pm | +112 | ▲ 2 | +32.7% | ₹455 |
| May 20, 2026 06:42 am | +110 | ▼ 2 | +32.1% | ₹453 |
| May 19, 2026 08:36 pm | +112 | — | +32.7% | ₹455 |
Q-Line Biotech IPO GMP — Detailed Analysis
What Q-Line Biotech GMP Tells Us Today
The current Grey Market Premium for Q-Line Biotech IPO is Rs 125 (36.4% over the issue price). Based on this GMP, the implied listing price hovers around Rs 468 per share. Across the 21 GMP records captured for this issue, the trend has been rising by Rs 13 — a useful directional signal for gauging investor sentiment as the listing date approaches.
Q-Line Biotech IPO is expected to list on May 29, 2026.
Q-Line Biotech IPO GMP — FAQs
New to grey market data? The hub covers how to read a GMP trend and how SME GMP compares with actual listing performance, and our explainer goes deeper: What is IPO GMP?